Headache Relief Tablet
Product Images NDC 11673-686

1 FDA label image from Target Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Headache Relief (NDC 11673-686). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Target Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Acetaminophen 250 mg, Aspirin 250 mg (nsaid)*, Caffeine 65 mg, *nonsteroidal Anti-inflammatory Drug (Extra Strength Headache Relief Geltabs 1)

Acetaminophen 250 mg, Aspirin 250 mg (nsaid)*, Caffeine 65 mg, *nonsteroidal Anti-inflammatory Drug (Extra Strength Headache Relief Geltabs 1)
Label for Headache Relief Extra Strength geltabs by TARGET Corporation. Each tablet contains acetaminophen 250 mg, aspirin 250 mg (NSAID), and caffeine 65 mg. The package contains 80 geltabs. The label highlights comparison to Excedrin Extra Strength and lists active ingredients, drug facts, uses, warnings, directions, and inactive ingredients. The product is for oral use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.